Psoriasis

Adults aged 18 years or older with a clinical diagnosis of plaque psoriasis of at least 6 months duration, may qualify for this research trial and receive investigational topical treatment (active study drug) or placebo.
Individuals must have the disease affecting 3%-15% of the body surface area (BSA) (excluding head) to be eligible for topical treatment. Adults must not have other types of psoriasis dominant other than plaque psoriasis. During the study period, participants must also agree not to have prolonged sun exposure. Eligible participants will have regular visits with our experienced research team.

There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 8 times over a period of about 24 weeks.

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigators
Dr Nisal Punchihewa
t: 9623 9464
e: [email protected]

Study Coordinator
Natasha Harrison
t: 9623 9435
e: [email protected]